UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

Diabetes (New York, N.Y.), 2009-09, Vol.58 (9), p.2018-2026

2009

Volltextzugriff (PDF)

High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy

PloS one, 2011-08, Vol.6 (8), p.e23589-e23589

2011

Volltextzugriff (PDF)

Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity

Journal of lipid research, 2009-02, Vol.50 (2), p.183-192

2009

Volltextzugriff (PDF)

Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus

Journal of the American College of Cardiology, 2008-12, Vol.52 (25), p.2190-2197

2008

Volltextzugriff (PDF)

Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes

Diabetologia, 2005-06, Vol.48 (6), p.1207-1215

2005

Volltextzugriff (PDF)

Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes

Diabetes care, 2010-02, Vol.33 (2), p.215-220

2010

Volltextzugriff (PDF)

PPARα: an emerging therapeutic target in diabetic microvascular damage

Nature reviews. Endocrinology, 2010-08, Vol.6 (8), p.454-463

2010

Volltextzugriff (PDF)

Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy

Diabetes care, 2010-02, Vol.33 (2), p.215-220

2010

Volltextzugriff (PDF)

Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDLs

Journal of lipid research, 2007-07, Vol.48 (6), p.1409-1416

2007

Volltextzugriff (PDF)

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes

Atherosclerosis, 2003-02, Vol.166 (2), p.387-394

2003

Volltextzugriff (PDF)

Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: A FIELD substudy

Atherosclerosis, 2011-11, Vol.219 (1), p.259-265

2011

Volltextzugriff (PDF)

Decreased High-Density Lipoprotein (HDL) Particle Size, Preβ-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families: Relationship With Intima-Media Thickness

Arteriosclerosis, thrombosis, and vascular biology, 2006-04, Vol.26 (4), p.897-902

2006

Volltextzugriff (PDF)

Correction: PPARα: an emerging therapeutic target in diabetic microvascular damage

Nature reviews. Endocrinology, 2010-09, Vol.6 (9), p.476-476

2010

Volltextzugriff (PDF)

Effects of Long-Term Fenofibrate Treatmen on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy

Diabetes care, 2010, Vol.33 (2), p.215-220

2010

Volltextzugriff (PDF)

Acute exposure to rosiglitazone does not affect glucose transport in intact human skeletal muscle

Metabolism, clinical and experimental, 2010-02, Vol.59 (2), p.224-230

2010

Volltextzugriff (PDF)

Globular adiponectin stimulates glucose transport in type 2 diabetic muscle

Diabetes/metabolism research and reviews, 2008-10, Vol.24 (7), p.554-562

2008

Volltextzugriff (PDF)

Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL

Journal of lipid research, 2007-06, Vol.48 (6), p.1409-1416

2007

Volltextzugriff (PDF)

PPARalpha: an emerging therapeutic target in diabetic microvascular damage

Nature reviews. Endocrinology, 2010-08, Vol.6 (8), p.454

2010

Volltextzugriff (PDF)

ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition and increased susceptibility for sphingomyelinase

Chemistry and physics of lipids, 2008-08, Vol.154, p.S13

2008

Volltextzugriff (PDF)

Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thickness

Arteriosclerosis, thrombosis, and vascular biology, 2006-04, Vol.26 (4), p.897

2006

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(15)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Humans
(13)
Science & Technology
(13)
Life Sciences & Biomedicine
(12)
Male
(12)
Middle Aged
(11)
Female
(10)
Biological And Medical Sciences
(9)
Medical Sciences
(8)
Type 2 Diabetes
(7)
Aged
(6)
Diabetes
(6)
Endocrinology & Metabolism
(6)
Fenofibrate - Therapeutic Use
(6)
Atherosclerosis
(5)
Diabetes. Impaired Glucose Tolerance
(5)
Endocrine Pancreas. Apud Cells
(5)
Endocrinopathies
(5)
High Density Lipoprotein
(5)
Risk Factors
(5)
Cardiology. Vascular System
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

High density lipoprotein structural changes and drug response in lipidomic profiles following the long-term fenofibrate therapy in the FIELD substudy

Serum, but not monocyte macrophage foam cells derived from low HDL-C subjects, displays reduced cholesterol efflux capacity

Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus

Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes

Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes

PPARα: an emerging therapeutic target in diabetic microvascular damage

Effects of Long-Term Fenofibrate Treatment on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy

Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDLs

Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes

Macrophage cholesterol efflux to plasma and HDL in subjects with low and high homocysteine levels: A FIELD substudy

Decreased High-Density Lipoprotein (HDL) Particle Size, Preβ-, and Large HDL Subspecies Concentration in Finnish Low-HDL Families: Relationship With Intima-Media Thickness

Correction: PPARα: an emerging therapeutic target in diabetic microvascular damage

Effects of Long-Term Fenofibrate Treatmen on Markers of Renal Function in Type 2 Diabetes: The FIELD Helsinki substudy

Acute exposure to rosiglitazone does not affect glucose transport in intact human skeletal muscle

Globular adiponectin stimulates glucose transport in type 2 diabetic muscle

Common ABCA1 variants, HDL levels, and cellular cholesterol efflux in subjects with familial low HDL

PPARalpha: an emerging therapeutic target in diabetic microvascular damage

ApoCIII-enriched LDL in type 2 diabetes displays altered lipid composition and increased susceptibility for sphingomyelinase

Decreased high-density lipoprotein (HDL) particle size, prebeta-, and large HDL subspecies concentration in Finnish low-HDL families: relationship with intima-media thickness

Suchergebnisse filtern